JULUCA cpr pell 50/25 mg bte 30 pce

7680667900016 CH-66790 J05AR21 08.03.0.
JULUCA cpr pell 50/25 mg bte 30 pce
JULUCA cpr pell 50/25 mg bte 30 pce
JULUCA cpr pell 50/25 mg bte 30 pce
1 / 3
google

Details

Product number
6679001
CPT
-
Packaging group
30
Unit
Tablette(n)
Composition
dolutegravirum 50 mg ut dolutegravirum natricum 52.62 mg, rilpivirinum 25 mg ut rilpivirini hydrochloridum 27.5 mg, mannitolum, cellulosum microcristallinum, povidonum K 29-32, carboxymethylamylum natricum, natrii stearylis fumaras, lactosum monohydricum 55.15 mg, carmellosum natricum conexum, povidonum K 30, polysorbatum 20, cellulosum microcristallinum silicificatum, magnesii stearas, Überzug: poly(alcohol vinylicus), macrogolum, talcum, E 171, E 172 (flavum), E 172 (rubrum), pro compresso obducto corresp. natrium 4.61 mg.

Articles (1)

Juluca 50 mg, Filmtabletten
Filmtabletten
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
09/09/2025
Patient information leaflet
Français
09/09/2025
Patient information leaflet
Italien
09/09/2025
Professional SmPC
Allemand
04/09/2025
Professional SmPC
Français
04/09/2025
Professional SmPC
Italien
04/09/2025

Detailed composition

Substance Quantity Type Category
dolutegravirum
50.0 MG Substance Wirkstoff (Principe actif)
dolutegravirum natricum
52.62 MG Substance WIZUS
rilpivirinum
25.0 MG Substance Wirkstoff (Principe actif)
rilpivirini hydrochloridum
27.5 MG Substance WIZUS
mannitolum
- Substance HNIDK
cellulosum microcristallinum
- Substance HNIDK
povidonum K 29-32
- Substance HNIDK
carboxymethylamylum natricum
- Substance HNIDK
natrii stearylis fumaras
- Substance HNIDK
lactosum monohydricum
55.15 MG Substance HBESI
carmellosum natricum conexum
- Substance HNIDK
povidonum K 30
- Substance HNIDK
polysorbatum 20
- Substance HNIDK
cellulosum microcristallinum silicificatum
- Substance HNIDK
magnesii stearas
- Substance HNIDK
poly(alcohol vinylicus)
- Substance HNIDK
macrogolum
- Substance HNIDK
talcum
- Substance HNIDK
E 171
- Substance FNIDK
E 172 (flavum)
- Substance FTODK
E 172 (rubrum)
- Substance FTODK
natrium
4.61 MG Substance HBESI

Reimbursement information

Public price
CHF 947.00
Specialties list
Yes
Generic
No
SL addition date: 01/02/2019

Authorization holder

ViiV Healthcare GmbH

6340 Baar

Authorization information

Swissmedic authorization number
66790
Drug name
Juluca, Filmtabletten
Galenic form
FILM
ATC Code
J05AR21
Authorization status
Z
Dispensation category
A
First authorization
06/12/2018
Authorization expiration date
31/12/9999
IT number
08.03.0.
Domain
Human medicine
Field of application
HIV Infektion

Packaging details

Description (FR)
JULUCA cpr pell 50/25 mg bte 30 pce
Description (DE)
JULUCA Filmtabl 50/25 mg Ds 30 Stk
Market launch
06/12/2018
Narcotic (BTM)
No
Buy us a coffee Explore the data